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NeurotrophinMacrophage migration inhibitory factor (MIF) plays versatile roles in the immune system. MIF is also widely
expressed during embryonic development, particularly in the nervous system, although its roles in neural
development are only beginning to be understood. Evidence from frogs, mice and zebraﬁsh suggests that
MIF has a major role as a neurotrophin in the early development of sensory systems, including the auditory
system. Here we show that the zebraﬁsh mif pathway is required for both sensory hair cell (HC) and sensory
neuronal cell survival in the ear, for HC differentiation, semicircular canal formation, statoacoustic ganglion
(SAG) development, and lateral line HC differentiation. This is consistent with our ﬁndings that MIF is
expressed in the developing mammalian and avian auditory systems and promotes mouse and chick SAG
neurite outgrowth and neuronal survival, demonstrating key instructional roles for MIF in vertebrate otic
development.
© 2011 Elsevier Inc. All rights reserved.Introduction
Critical extracellular signals are involved in the development of
vertebrate inner ear innervation (Barald and Kelley, 2004). Cultured
mouse and chick otocysts release protein(s) collectively termed
otocyst-derived factor (ODF) that promote neurite outgrowth and
survival of embryonic statoacoustic ganglion (SAG) neurons in vitro,
which are also thought to direct innervation in vivo (Ard, et al.,
1985; Bianchi and Cohan, 1991; Bianchi et al., 2005; Lefebvre et al.,
1990). These functions have been thought to be controlled by
neurotrophins (neurotrophic factors), deﬁned as target-generated
directional neurite outgrowth promoting and neuronal survival
promoting factors such as nerve growth factor (NGF; Purves et al.,
2001). However, proteomic and array analysis of ODF demonstrates
that it does not contain any known classical neurotrophins (Bianchi
et al., 2005), suggesting that ODF growth factor(s) that promote theelopmental Biology, 3053 BSRB
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e, Division of Pulmonary and
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rights reserved.initial outgrowth and survival of SAG neurons are novel. Faced with
the apparent paradox of neurotrophic action in the absence of classical
neurotrophic factors, we set out a number of years ago to determine
which components in ODF fulﬁlled that role in vivo and in vitro.
Both our earlier (Bianchi et al., 2005) and recent work (Bank et al.,
submitted) demonstrate/d that chick and mouse otocyst-derived ODF
includes at least 3 “immune system” cytokines, one of which is the
immune system “inﬂammatory” cytokine macrophage migration
inhibitory factor (MIF; Bank et al., submitted). MIF, known for its
involvement in T-cell (Larson andHorak, 2006) and B-cell development
(Takahashi et al., 1999); shares no sequence similarity with classical
neurotrophins or with other known cytokines (Weiser et al., 1989),
but is related to D-dopachrome tautomerase (DDT) (Esumi et al.,
1998).We found bothMIF (mif) and the tautomerase (mif-like) expres-
sion in the zebraﬁsh. Inmammals,MIF protein andmRNAare expressed
in CNS neurons (Bacher et al., 1997; Bacher et al., 1998; Nishino et al.,
1995) and MIF is involved in neuronal degeneration-regeneration
processes (Koda et al., 2004; Nishio et al., 1999; Yoshimoto et al.,
1997). Most signiﬁcantly, MIF mRNA is found in the developing
neuraxes and nervous systems of Xenopus (Suzuki et al., 2004), mouse
(Kobayashi et al., 1999) and zebraﬁsh (Holmes et al., 2011; Ito et al.,
2008) and is a critical player in establishing the neuraxis of the embryo
(Suzuki et al., 2004).
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et al., 2004), and zebraﬁsh (Holmes et al., 2011; Ito et al., 2008).
MIF message and protein are also found in the mouse (Kobayashi et
al., 1999) and chick (Bank et al., submitted) inner ears in early
pre-sensory regions of the otocyst and in supporting cells in adults.
MIF−/− mice are hearing-impaired as early as 4 weeks postnatally,
with signiﬁcantly fewer spiral ganglion neurons (SGN) and sensory
HC than wild type mice of the same genetic background (Bank et
al., submitted).
The best-known MIF receptor, CD74 (Leng et al., 2003), is
expressed on the surface of inner ear neurons. In the mouse and
chick, we have found that CD74 is found on both early stage SAG
and adult SGN (Bank et al., submitted). Two zebraﬁsh homologs of
CD74, invariant chain like protein 1 and 2, (iclp1, 2, recently renamed
cd74a and cd74b respectively), have been cloned (Yoder et al., 1999),
but their embryonic expression patterns had not previously been
described prior to this report.
In this study, we have explored the MIF signaling components and
further deﬁned their function by knockdown with antisense oligonu-
cleotide morpholinos (MOs) or, in parallel experiments, with a
biochemical MIF inhibitor. We report the developmental expression of
the second zebraﬁsh mif family member, mif-like, and the expression
patterns for the receptors for both mif and mif-like receptors, iclp1
and iclp2 in the embryo and in the inner ear.
We found that perturbations ofMIF signaling resulted in a signiﬁcant
reduction in the size of the SAG, the number of sensory HC and the size
of the brain in zebraﬁsh. We demonstrate that these reductions take
place, at least in part, by a p53-dependent mechanism. Both MIF-
dependent mouse macrophage survival (Mitchell et al., 2002) and
MIF's ability to prevent apoptosis in regenerating rat peripheral nerve
Schwann cells (Nishio et al., 2002) also depend on MIF inhibition of
p53-dependent apoptosis. Therefore, the involvement of p53—at least
in part—in MIF regulation of both sensory hair cell numbers and
numbers of SAG neurons is consistent with the involvement of MIF
and p53 in apoptosis in other systems.
Material and methods
Zebraﬁsh maintenance, embryo collection, and embryo husbandry
Wild type zebraﬁsh were obtained from University Aquarium, Ann
Arbor or local pet stores, Penang, Malaysia and kept on a 14:10 h
light/dark cycle at 28.5 °C.
Embryos were raised at 28.5 °C in methylene blue (0.3 ppm) ﬁsh
water to prevent fungal growth. For in situ hybridization (ISH)
experiments, 0.03% 1-phenyl-2-thiourea (C6H5NaHCSNH2/PTU,
Sigma) was added (1:10) around 12 hpf to prevent pigmentation.
Embryos were observed or ﬁxed in 4% paraformaldehyde (PFA) in
phosphate buffered saline (PBS; 1×PBS, pH 7.3) at the time/stage
indicated, rinsedwith PBST (0.1% Tween-20 in 1×PBS), and dehydrated
in methanol and stored at−20 °C. These methods were adapted from
Westerﬁeld (2000). The mif inhibitor, 4-iodo-6-phenylpyrimidine
(4-IPP; Specs, Delft, Netherlands), was used to treat embryos at
6–7 hpf immediately after dechorionation with 10 mg/ml Pronase
(2 min, and 2× rinse with ﬁsh water). The embryos were incubated in
30–40 μM4-IPP in 32 mMDMSO, at 28.5 °C until observation or ﬁxation
for further reactions and subsequent observation.
RT-PCR analysis
To assay developmental expression ofmif and iclp transcripts, total
whole embryo RNA was isolated with Trizol (Invitrogen). RNA was
reverse-transcribed with the Superscript III system (Invitrogen) and
PCR performed using Jumpstart Taq polymerase (Sigma-Aldrich).
The fragments ampliﬁed are nucleotides 15–526 for mif-like,
98–620 for iclp1, and 51–575 for iclp2. Primer positions used inthese studies are illustrated in Fig. 1. The predicted size of the
RT-PCR products is 512 bp for mif-like primer pair, 523 bp for iclp1,
and 525 bp for iclp2, respectively.In situ hybridization
RT-PCR was used to amplify cDNA fragments for probe templates
and RT-PCR products cloned into the pCRII-TOPO vector (InVitrogen)
and digested with either EcoRV or BamHI restriction enzymes to
produce templates for sense and antisense probes, respectively. After
column puriﬁcation of digested template DNA (MinElute Reaction
Cleanup kit, Qiagen), synthesis was performed using a DIG RNA label
with T7 polymerase or SP6 polymerase. Whole mount ISH was
performed as previously described (Shen et al., 2008). Hybridizations
were detected using an alkaline-phosphatase-conjugated antibody
and visualized with 4-nitroblue tetrazolium/5-bromo-4-chloro-3-
indolyl phosphate (NBT/BCIP; Roche). Embryos were observed under
a Leica MXFL III stereo dissecting microscope; photos were taken
with an Olympus DP-71 Digital camera and processed with Adobe@
Photoshop. Sectionswere observed andphotographedwith anOlympus
BX-51 compound microscope.Morpholino injections
Morpholinos (MOs, Gene Tools, Corvallis, OR)were designed based
on zebraﬁsh genomic sequences of mif, mif-like, iclp1, and iclp2: An
antisense MO, complementary to the start codon of zebraﬁsh mif
mRNA: 5′-ACATCGGCATGACTGCGACAGAGAT-3′. Two MOs were
used for mif-like. mif-like MO1 is complementary to the translational
start site: 5′-GTTTCTATATTTATGAACGGCATGA-3′, while mif-like
MO2 derived from AS sequence at the intron 1/exon 2 boundary: 5′-
GATTCATCCTCTGAAGACGTAAGCC-3′. MOs are complementary to the
boundary of exon 2 and intron 2 of iclp1 and iclp2 pre-mRNA: iclp1MO:
5′-TGTTTTGTGTGTTTACGCACCTGAC-3′; iclp2MO: 5′-CGTGCTATGGTTT
2TCTGACCAGATT-3′.
Control MO was the scrambled nucleotide sequence from Gene
Tools: 5′-CCTCTTACCTCAGTTACAATTTATA-3′.
MOs were microinjected into the yolk of 1–8 cell embryos with a
PV820 Pneumatic PicoPump (World Precision Instruments) and an
attached Nitrogen tank according to our previously published
procedures (Shen et al., 2008). Injection conditions: volumes of either
1 nl or 2 nl: 0.3 mM for mif, mif-like MO1, and mif-like MO2. iclp MOs
were used in combination (0.5 mM for iclp1 MO,1 mM for iclp2 MO).
Five nanograms of p53 MO was combined in the 0.3 mM mif MOs.
RNA prepared from injected embryos at 50 hpf was reverse-
transcribed and ampliﬁed with primer sets for mif-like, iclp1, and
iclp2 to evaluate the efﬁcacy of knockdown with mif-like MO2, iclp1,
and iclp2, respectively. RT-PCR products were separated by size on
1.5% agarose gels, visualized by ethidium bromide.Morphology and cell death assays
Injectedﬁshwere observed between 25 hpf and 48 hpf under aMXFL
III microscope (Leica). Acridine Orange [AO, 3, 6-bis(dimethylamino)
acridine zinc chloride double salt; Sigma] was used to detect cell death
in embryos as described previously (Shen and Raymond, 2004). Living
embryos were dechorionated and stained with 5 μg/ml AO in embryo-
rearing media (Westerﬁeld, 2000) for 10 min and then rinsed with
media. Dead cells incorporating AO were visualized with a MXFL III
stereo microscope with a ﬂuorescent channel (Absorption
460–550 nm, Beam splitter 505 nm, and Emission at 510 nm), and
photographed with an Olympus DP-71 Digital camera. AO-labeled
cells were counted with the magniﬁed photograph using Adobe@
Photoshop.
Fig. 1. Gene structures of zebraﬁsh mif, mif-like, iclp1, and iclp2. (A) Comparison of zebraﬁsh mif, mif-like and their human orthologs. Gray boxes: open reading frames for the
predicted proteins; white boxes: untranslated regions; lines indicate introns; Stars: stop codons. Positions of morpholinos (MOs) are underlined. Arrows indicate the primers
used to obtain RT-PCR products in Figs. 2 and 4. (B) Genomic structure of zebraﬁsh iclp1 and iclp2. MO positions indicated. Arrows indicate primers for RT-PCR products in
Figs. 3 and 4.
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Embryos or larvae were ﬁxed in 4% PFA/PBS, treated with PBS/1.5%
Triton X-100 for 1–2 days at 4 °C, incubated with Texas red-phalloidin
(1:200 dilution, Molecular Probes) in PBS/BSA/DMSO (PBD;
Westerﬁeld, 2000) overnight at 4 °C and rinsed multiple times with
PBD. For zn-5 immunolabeling, embryos were incubated with zn-5
antibody (1:500 dilution, ZIRC) followed by Alexa Fluor 488-goat
anti-mouse secondary antibody (Molecular Probes). Embryos or
larvae were viewed with an Olympus FV500 confocal microscope.
The z-stacks of confocal pictures as well as the SAG were outlined
and the area of the SAG calculated with MetaMorph@ image analysis
software.
Lateral line (LL) hair cell staining
Physiologically active HC in neuromasts were labeled by exposure
to 4-Di-2-ASP (4-(4-Diethylaminostyryl)-1-methylpyridinium iodide,
Sigma D-3418) (previously described: Shen et al., 2008). Embryos or
larvae were incubated in 0.005% 4-Di-2-ASP in fresh embryo water
(Westerﬁeld, 2000) 28.5 °C/30 min. After a short embryo water
rinse, embryos or larvae were observed and photographed under a
MXFL III microscope.
RNA-mediated gain of function (rescue) experiments
Open reading frames (ORFs) of mif, mif-like, iclp1 and iclp2 were
ampliﬁed using RT-PCR and cloned into pCS2+ vector. Capped RNA
was synthesized using a mMESSAGE mMACHINE Sp6 in vitro
transcription kit (Ambion Inc., Austin, TX). RNAs were diluted into
100 ng/μl and co-injected with the corresponding morpholinos.
Statistical treatment of data: One-tailed T-tests were used to
assess the signiﬁcance of the data. The error bars indicate standard
deviation.Results
Expression patterns of zebraﬁsh mif and mif-like
Two zebraﬁsh mif-like genes, one with higher homology to the
mammalian MIF gene, and the other with a higher homology to the
mammalian DDT gene were identiﬁed in a GenBank search. The ﬁrst
cDNA delineating complete mif cDNA (GenBank ID: DQ639953.1),
matched the DNA sequence from clone DKEYP-121D2 on chromosome
14 (NCBI Reference Sequence ID: NC_007125.4; Ito et al., 2008). The
second cDNA, which we named mif-like, (GenBank ID: BC071391.1),
was mapped to sequences from Danio rerio chromosome 21 (NCBI
Reference Sequence ID: NC_007132), syntenic to the human MIF and
DDT genes on chromosome 22q11.23 (http://uswest.ensembl.org).
The zebraﬁsh mif coding sequence predicts a protein with 115 amino
acids, the same as mammalian MIF (Weiser et al., 1989). The predicted
protein is 69% identical to human MIF. The gene structure of the zebra-
ﬁshmif is very similar to that of humanMIF, with only slight variations
in exon length and large variations in intron length (Fig. 1A).
The coding region of the zebraﬁsh mif-like gene encodes a
predicted protein of 118 amino acids, the same size as themammalian
DDT (Esumi et al., 1998). Mif-like protein is less homologous to the
mammalian proteins. Both zebraﬁsh mif and mif-like contain all of
the amino acid residues conserved among all MIF family genes found
in different species (Esumi et al., 1998). The gene structure of mif-
like is the same as the human DDT, although the non-coding exon 1
in human DDT has not been found in the mif-like gene (Fig. 1A).
Developing zebraﬁsh mRNA expression patterns for mif and mif-
like are very similar, with stronger expression of the mif signal. We
detected mif signal as early as 12 hpf in the anterior part of the
embryos (Figs. 2B, F), and as shown in Ito et al. (2008), mif mRNA is
expressed strongly in the midbrain and eye at 24 hpf (Fig. 2J), and
in the midbrain at 36 hpf and 48 hpf (Figs. 2N, O), when eye
expression is reduced. Branchial arches and pectoral pin buds also
express mif. Expression of mif is detected in the otic vesicle (Figs. 2J,
Fig. 2. Expression ofmif andmif-like transcripts in the brain, eye and ear during embryogenesis. (A) RT-PCR results ofmif-likemRNA fromwhole embryos at 12, 26, 36, 54, 60, and 72 hpf.
(B–U)Wholemount ISHwithmif ormif-like probes. (B–E) Dorsal view of 12-hpf embryos; (F–I) Dorsal view of 14-hpf embryos; (J–M) Lateral view of 24-hpf embryos; (N, P) Lateral view
of 36-hpf embryos; (O, Q) Lateral viewof 48-hpf embryos; (R–U) Lateral viewof 72-hpf larvae. (B, F, J, N, O, R)mif antisense probe; (C, G, K, S)mif sense probe; (D, H, L, P, Q, T)mif-like anti-
sense probe; (E, I, M, U) mif-like sense probe. Insets in (O) and (Q) show transverse sections through the ear; the small arrow in inset (Q) indicates hair cells in the anterior macula.
Arrowheads: brain; OptV: optic vesicle; OV: otic vesicle; white arrows with black outlines: pectoral ﬁn bud. Scale bar: 100 μm for (B–U); 20 μm for insets.
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through the otocyst showed that mif is expressed in the lateral
epithelial cells (Fig. 2O inset).
Mif-like mRNA is detected by 12 hpf by RT-PCR; levels become
higher at 26 hpf and remain throughout the stages tested till 72 hpf
(Fig. 2A). Whole mount ISH shows that mif-like is expressed in the
eye, strongly in the lens, moderately in the otic vesicle and weakly
in the brain at 24 and 36 hpf (Figs. 2L and P). The expression in the
lens is reduced by 48 hpf (Fig. 2Q), but moderate expression in the
otic vesicle and brain is detectable until at least 72 hpf (Figs. 2Q, T).
In the otic vesicle, mif-like is detected in the lateral epithelial cellsand very weakly in the hair cells of the anterior macula (Fig. 2Q
inset). No expression was detected with any of the sense probes
(Figs. 2C, E, G, I, K, M, S and U). This expression pattern is very similar
to that of stage 34 Xenopus Mif (Suzuki et al., 2004) and embryonic
mouse Mif expression (Kobayashi et al., 1999) in the brain, eye
capsule and otocyst. Expression of zebraﬁsh mif and mif-like has not
been detected in ﬁsh somites as in mouse (Kobayashi et al., 1999)
and Xenopus. Zebraﬁsh mif and mif-like are expressed prominently
in the inner ear at times of critical differentiation steps in its develop-
ment, including SAG delamination and formation, implying their roles
in the process.
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Two zebraﬁsh homologs of the mammalian MIF receptor, CD74,
have been cloned and named invariant chain-like proteins 1 and 2
(Iclp1 and Iclp2, GenBank ID: AF148214 and AF116539, respectively;
Yoder et al., 1999). Based on the overall homology and predicted
structures, iclp1 is more likely to be functionally equivalent to
mammalian CD74 (Yoder et al., 1999). Abundant expression of both
iclp1 and 2 is detected in the adult kidney, and much lower levels of
expression are found in the spleen, liver, and intestine (Yoder et al.,
1999). We examined the expression of iclp1 and iclp2 in embryonic
zebraﬁsh. Both genes are expressed as early as 12 hpf, with iclp1
weaker at this stage, and throughout the stages tested (72 hpf).
Although expression levels of both genes fall at 36 hpf, higher levels
are again seen at 72 hpf (Fig. 3A). Whole mount ISH experimentsFig. 3. Expression patterns of embryonic iclp1 and iclp2. (A) RT-PCR results of iclp1 and iclp
mount ISH with iclp1 (B–H) or iclp2 (K–R) probes. (B, C, K, L) Dorsal view of 14-hpf embr
(G, P) 48-hpf embryos; (H, Q, R) 72-hpf larvae. (B, D, F, G, H) with iclp1 antisense probe; (
iclp2 sense probe. (I, J) iclp1 labeling of 48 hpf embryo with transverse (I) and sagittal (J)
and (P) show transverse sections of the ear; Inset (G) inset shows a section through the
Inset (H) shows a tail with posterior LL neuromast staining. OV: otic vesicle. Arrowheads
black outlines: pectoral ﬁn bud; white arrowhead with black outline: statoacoustic ganglioshowed weak expression of iclp1 at 14 hpf in the anterior part of the
embryo (Fig. 3B), and in the otic vesicle at 24 hpf, 36 hpf, 48 hpf and
72 hpf (Figs. 3D, F, G and H); iclp2 was expressed at a moderate level
at 14 hpf (Fig. 3K), weakly in the otic vesicle at 24 hpf (Fig. 3M), and
at higher levels at 36, 48, and 72 hpf (Figs. 3O, P, and Q). In sectioned
developing otocysts, we found that both iclp1 and iclp2 were
expressed in the lateral epithelial cells of the otocyst (Figs. 3G and P
insets). Additionally, iclp1 is expressed in the hair cells (HC) of both
the anterior macula (Figs. 3I and J) and posterior macula (Fig. 3G
inset). Very weak expression was also detected in the SAG at the
same stage (Fig. 3I). There is also expression of iclp1 at 36 and 48 hpf
in the pectoral ﬁn bud (Figs. 3F and G). No signal was detected with
sense probes (Figs. 3C, E, L, N, and R). That zebraﬁsh mammalian
CD74 homologs are present in the developing inner ear further
supports a role for mif in inner ear development.2 transcripts from whole embryos of 12, 26, 36, 54, 60, and 72 hpf. (B–H, K–R) Whole
yos; (D–H, M–R) Lateral view of (D, E, M, N) 24-hpf embryos; (F, O) 36-hpf embryos;
C, E) with iclp1 sense probe; (K, M, O, P, Q) with iclp2 antisense probe; (L, N, R) with
sections. Arrows in (I) and (J) indicate hair cells in the anterior macula. Insets in (G)
posterior macula; small arrow in inset (G) indicates hair cells in the sensory patches.
: anterior LL neuromasts; white arrows: posterior LL neuromasts; white arrows with
n (SAG). Scale bar: 100 μm for (B–H) and (K–R); 20 μm for insets, (I) and (J).
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(Figs. 3D, F, G, and H), more strongly in the anterior than posterior
LL, indicating it might also be involved in LL development.
Mif pathway is important for the morphogenesis of zebraﬁsh embryos
The expression of mif, mif-like, iclp1, and iclp2 in the otic vesicle
during inner ear morphogenesis, especially SAG delamination and
HC differentiation, suggested that the mif pathway might be involved
in these processes. We therefore combined mif and mif-like MOs for
injections to produce mif morphants, and iclp1 and iclp2 MOs to
obtain iclp morphants.
To examine the efﬁcacy of the MOs, we isolated total RNA from
controls, morphants, and morphants that had also received capped
RNA injections at 50 hpf, performing RT-PCR to amplify regions
containing the predicted splice-blocking sites (Figs. 1A, B). Mif-like
MO2 blocks the splicing of intron 1, resulting in the deletion of exon
2. The predicted mRNA is 176 bp shorter than the normal transcript.
As shown in Fig. 4A, mif morphants had both a shorter transcript
and a much reduced quantity of the normal one. With coinjection of
mif-like capped RNAs, the amount of normal transcript increased,
although not to the level of the control, and a reduced amount of
the shorter fragment without exon 2 was also detected. This could
have led to low efﬁciency of rescue (see later). For both iclp1 and
iclp2, shorter fragments were not detected in morphants (Fig. 4B),
but the levels of the normal mRNAs were largely decreased compared
to those of the controls (Fig. 4B). This could be due to the instability of
the shorter mRNA, as we also observed in Shen et al. (2008). With
RNA “rescue”, levels of the normal transcript were regained (Fig. 4B).
Iclp1 and iclp2 morpholinos alone caused many fewer phenotypic
changes than mif MOs, even at 1 mM and 2 mM, respectively (data
not shown). However, the combination of iclp1 and iclp2morpholinos
at 0.5 mM and 1 mM resulted in ventrally curled embryos, while the
size of the brain was not greatly reduced (Figs. 5C and R). This is
contrary to what is seen with the mif morphants, which have much
smaller heads and overall attenuated nervous systems, including the
eye and the ear regions (Figs. 5B and Q).
Several chemicals inhibitMIF, including (S,R)-3-(4-hydroxyphenyl)-
4, 5-dihydro-5-sioxazole acetic acid methyl ester (ISO-1; Lubetsky et al.,
2002), a ﬂuorinated analog of ISO-1, ISO-F (Dagia et al., 2009),
Trichostatin A (TSA; Lugrin et al., 2009), and4-iodo-6-phenylpyrimidineFig. 4. Morpholinos reduced the levels of normal transcripts of mif-like, iclp1, and iclp2.
(A) RT-PCR of mif-like transcripts from uninjected, control MO injected, mifmorpholinos
injected and mif morpholinos plus capped RNAs injected 50-hpf embryos. Predicted size
of normal transcript is 512 bp; predicted transcript blocked by mif-like MO=336 bp.
(B) RT-PCR of iclp1 and iclp2 transcripts from control MO-injected, iclp morpholinos
injected and iclpmorpholinos plus capped RNAs injected 50-hpf embryos. Predicted size
of normal iclp1 product=523 bp, transcript lacking exon 2=353 bp. Predicted size of
normal iclp2 product=525 bp, transcript lacking exon 2=364 bp.(4-IPP; Winner et al., 2008). All of these chemicals but TSA inhibit mif
dopachrome tautomerase activity in vitro (Dagia et al., 2009; Lubetsky
et al., 2002; Winner et al., 2008). TSA is a histone deacetylase inhibitor
that inhibits mif transcription through a local chromatin deacetylation
(Lugrin et al., 2009), but it also affects expression of other genes as
well as inducing cell cycle arrest and cell death (Noh et al., 2009).
We have examined the impact of ISO-1 and 4-IPP on zebraﬁsh
embryonic development, and found 4-IPP to be much more potent
than ISO-1 (data not shown); hence we used 4-IPP for all further
experiments. The effect of 4-IPP on embryos is dose-dependent.
With more than 50 μM 4-IPP, more than half of the embryos did not
survive for 2 days. Therefore, the highest concentration used for
4-IPP incubation was 40 μM. We found that treatment with 4-IPP
resulted in less pigmentation and in minor gross defects in the
embryos (Fig. 5E) when compared to the DMSO control (Fig. 5D),
but the chemical inhibitor's effect is much less pronounced than the
effects of mif or even iclp morpholino injections. However, when we
examined these embryos at later stages, we found remarkable ear
defects in these embryos (see later).
As Ito et al. (2008) had previously observed, we saw dramatically
increased cell death in the brain ofmifmorphants (Fig. 5G) compared
to control MO-injected embryos (Fig. 5F). The AO-positive cells are
spread throughout the otocyst in mif morphants (Fig. 5U). However,
consistent with the results on embryo size, cell death in the brain of
iclp morphants was not as pronounced as in mif morphants
(Figs. 5H, M). Quantitative results showed that the number of dead
cells found in the ear doubled in mif morphants. This increased cell
death could be partially rescued by mif RNA injection (Fig. 5S) or by
injection of 5 ng of p53 MO (Fig. 5T). There was a slight increase in
cell death in 4-IPP-treated embryos as well (Figs. J and O) compared
to embryos treated with DMSO vehicle only (Figs. 5I and N).
Mif pathway and zebraﬁsh inner ear development
Ito et al. (2008) demonstrated that mif is critical for brain and
optic vesicle development. The effects of mif MOs in the otic vesicle
were not examined in that report. To investigate the role of the mif
pathway in inner ear development, we ﬁrst performed whole
mount ISH with several inner ear markers, including fgf8, dlx3b,
dlx4b, tlxA, and pax2b. Expression patterns of these genes were not
different between the mif morphants and controls (data not
shown), indicating that early events of inner ear development such
as organogenesis and speciﬁcation were not affected by the mif
MOs. However, increased cell death in the inner ear could result in
defects of inner ear structure. To detect any ﬁne structural changes
in mif morphants, we used confocal microscopy to observe sensory
HC patches, formation of semicircular canals, and SAG development.
The three cristae in the mif and iclp morphants were normal in
shape and kinocilia length (data not shown). However, when the
stereocilia were stained with phalloidin, reduced HC numbers were
observed in the saccular macula in both mif (Figs. 6B and G) and iclp
morphants (Figs. 6D and I) at 3 dpf and 6 dpf, although the numbers
of HC continued to increase over time (Fig. 6K). A similar reduction
in phalloidin-positive cells in the morphants was detected in the
utricular macula (data not shown). Concomitant RNA injection partly
rescued macular HC development (Figs. 6C, E, H, J, and K).
4-IPP also reduced the number of hair cells stained with phalloidin
at 4 dpf in a dosage-dependent manner (Fig. 6L), further supporting
the importance of mif function in HC development.
Formation of semicircular canals (SCC) was also defective in the
mif morphants. By 3 dpf, epithelial pillars should have formed from
the fusion of the central bulges and the peripheral projections from
all directions (anterior, posterior, and ventral; Figs. 7A, F, and K;
Waterman and Bell, 1984). However, in more than half of the mif
morphants, fusion of the bulges and the projections was incomplete
(Fig. 7B). This is not likely due to developmental delay, because fusion
failure was found in morphants at much later stages (4 and 5 dpf,
Fig. 5. Gross morphology was affected by mif and iclp morpholinos. Lateral view of embryos at 29 hpf (A–E) and 48 hpf (P–R). (F–O) Acridine orange (AO) staining demonstrated
cell death in 29-hpf embryos. (K–O) Magniﬁed ear area in (F–J) respectively. (A, F, K, P) control; (B, G, L, Q)mifmorphants; (C, H, M, R) iclpmorphants; (D, I, N) DMSO control; (E, J,
O) 4-IPP (40 μM)-treated embryos. White oval outlines indicate the positions of the otocysts; white arrowheads point to the AO-stained cells in the otocysts. (S, T) Comparison of
AO-stained cells in the inner ear (n=4 for each treatment in (S), and n=5 for wt, 8 for both mif MOs and mif MOs+p53 MO in (T)) at 29 hpf. (U) Illustration of the location of
AO-positive cells in the otocyst. The different colors of the spots represent AO-positive cells in the different embryos assessed. They are superimposed in this ﬁgure to determine
if cells in a particular region were more susceptible (n=5 for wild type, and 8 for mif morphants). Scale bar: 100 μm.
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but the posterior and ventral SCC were more affected. In morphants
co-injected with capped RNA, normal SCC formation was largely
restored (Figs. 7C, H, and M). The defects of SCC in the iclpmorphants
(Figs. 7D, I, and N) were much milder than in mif morphants. RNA
injections almost always completely rescued the canal phenotype of
the iclp morphants (Figs. 7E, J, and O). Embryos and larvae treated
with 4-IPP had similar defects in SCC formation, although these
were not as severe as mif morphants (data not shown).
Mif signalling and cranial ganglia development
Recombinant Mif promotes isolated SAG neurite outgrowth and
survival in chick and mouse (Bank et al., submitted). To determine
whether mif has the same function in zebraﬁsh, we examined mor-
phant SAGs as well as SAGs from 4-IPP-treated embryos. To observe
early stage SAG development, we performed whole mount ISH using
an nkx5.1 (hmx3) probe. The expression of nkx5.1/hmx3 is detected in
the otic placode and vesicle and in the cells forming the SAG
(Adamska et al., 2000; Feng and Xu, 2010). Our results showed reducedsignal of nkx5.1 in the developing ear and SAG in mif morphants
(Fig. 8B), iclp1 morphants (Fig. 8D), and mif inhibitor (4-IPP) treated
(40 μM) embryos (Fig. 8F), indicating a reduction in SAG neuroblasts.
4-IPP at 30 μM did not cause as much reduction of nkx5.1 expression
(Fig. 8E) as 40 μM.Monoclonal antibody zn-5wasused to label differen-
tiating neurons and their processes at 48 hpf. Zn-5 can be used to label
the SAG, trigeminal cranial ganglia, and anterodorsal lateral line ganglia
(gAD) (Wilson et al., 2007).MifMOs treatment resulted in much smal-
ler SAGs and gADs (Fig. 8H) compared to controls (Fig. 8G), while iclp
MOs did not have a signiﬁcant effect on the size of the ganglia
(Fig. 8J). Neuronal processes in the brain are also shorter in mif mor-
phants (Fig. 8H). Concomitant RNA injection improved both the sizes
of the ganglia (Figs. 8I, K, and L) and length of the neuronal processes
(data not shown).
Iclp and lateral line (LL) development
iclp1 expression in lateral line (LL) neuromasts suggests that it has
a function in LL development. We investigated active neuromast HC
with a mitochondrial dye, 4-Di-2-ASP. 4-Di-2-ASP staining of iclp
Fig. 6. Phalloidin staining of the sensory hair patch showed defects in mif and iclp morphants. (A–J) Phalloidin staining of saccular macula with 3d (A–E) and 6d (F–J) larvae.
Anterior is to the left. (K) Numbers of HC labeled by phalloidin at 3 dpf (n=9 for control, 10 for mif morphants, 13 for mif morphants with RNA rescue, 2 for iclp morphants, 6
for iclpmorphants with capped RNA) and 6 dpf (n=4 for control, 7 formifmorphants, 3 formifmorphants with RNA rescue, 5 for iclpmorphants, 6 for iclpmorphants with capped
RNA). (L) Numbers of HC labeled by phalloidin at 4 hpf (n=14 for DMSO control, 9 for 30 μM 4-IPP, 12 for 40 μM 4-IPP treatment). Scale bar: 10 μm.
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(Fig. 9B), but there were fewer active neuromasts in both anterior and
posterior LLs (Fig. 9H). Phalloidin staining of neuromast HC also
showed reduced postive cell numbers in iclp morphants (Fig. 9E)
compared to controls (Fig. 9D), indicating that there are HC defects
in the neuromasts of the LL. In additional experiments in which
capped RNA for both receptors was introduced along with the MOs,
a partial rescue was achieved (Figs. 9C, FG and data not shown).Fig. 7. Semicircular canal formation in mif and iclpmorphants. (A–O) phalloidin staining of
(K–O) 5 dpf larvae. (A, F, K) control; (B, G, L)mifmorphants; (C, H, M)mifmorphants with ca
Anterior is to the left. Arrows: junction of the posterior bulge (pb) and posterior protrusion (
Stars: junction of the anterior protrusion (ap) and the anterior bulge (ab). In mif morphan
25 μm. n=11 for the 3 dpf control, 12 for the 3 dpf mif morphants, 4 for the 3 dpf mif M
4 dpf is 7 for the controls, 6 for themifmorphants, 6 for themifMOs+RNA, 11 for the iclpm
For 5 dpf larvae, n=6 for control, 7 for mif morphants, 7 for mif MOs+RNA, 5 for iclp mo
defects.Discussion
That immune system cytokines play important neurotrophic
roles in the developing nervous system is not a new idea
(reviewed in Deverman and Patterson, 2009), but the identiﬁca-
tion of MIF (mif)'s neurotrophic roles in the early developing
inner ear and its effects on both innervation and sensory hair
cell development is novel. Zebraﬁsh in which mif was knockedepithelial pillars (ep), which form hubs of the developing SCC. (A–E) 3 dpf; (F–J) 4 dpf;
ppedmif RNAs; (D, I, N) iclpmorphants; (E, J, O) iclpmorphants with capped iclp RNAs.
pp). Arrowheads: junction between the ventral bulge (vb) and ventral protrusion (vp).
ts, a gap between the pb and the pp was observed, indicating fusion failure. Scale bar:
Os+RNA. Among the 12 mif morphants, 9 had defects in SCC formation (75%). n for
orphants, 5 for the iclpMOs+RNA. Four out of 6 (67%) mifmorphants had SCC defects.
rphants, 6 for iclp MOs+RNA. Eighty six percent (6 out of 7) mif morphants had SCC
Fig. 8. Statoacoustic ganglion in the mif, iclp morphants and 4-IPP treated embryos. (A–F) Whole mount in situ hybridization of embryos with an nkx5.1 probe, showing the otic
vesicle and SAG at 32 hpf. (A) control embryo; (B) mif morphant; (C) mif morphant with RNA; (D) iclp1 morphant; (E, F) 4-IPP treated (E: 30 μM, F: 40 μM) embryos. (G–K)
zn-5 staining in 48-hpf embryos. (G) control; (H) mif morphant; (I) mif morphant with capped mif RNAs; (J) iclp morphant; (K) iclp morphant with capped iclp RNAs. The
white line outlines the SAGs. Note other cranial ganglia were also smaller in the mif morphants than the control. gAD: anterodorsal LL ganglia. Scale bar: 25 μm. (L) Comparison
of size of the SAG with various treatments. Control embryos (n=30), mif MOs (n=14), mif MOs+RNA (n=12), iclp MOs (n=17), and iclp MOs+RNA (n=15).
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(Fig. 8), which can be rescued by co-injection of capped mif RNA.
Based on the work of Suzuki et al. (2004) in Xenopus, effects on
neurulation and neural axis formation were expected in our experi-
ments; injections of MOs to both mif and mif-like in combination,
reduced the overall size of the CNS through apoptosis. However,
because such effects could represent non-speciﬁc toxic effects of
MOs introduced into the 1–8 cell stage embryo, which has effects
on the brain and other parts of the CNS as well as the ear, we have
also successfully introduced combined MOs directly into the nascent
zebraﬁsh inner ear at 24 hpf and electroporated them into speciﬁc
ear quadrants (Holmes et al., 2011). We found that we can speciﬁcally
alter inner ear development and innervation without affecting
nervous system development in the embryos in which the otic vesicle
alone was injected (Holmes et al., 2011). The possible toxic effects of
MOs on whole embryos injected at the 1–8 cell stages are therefore
not affecting inner ear differentiation.
We only observed partial rescue with RNA injections in mif
morphants, in which the levels of the normal mif-like transcript
were drastically lowered and a transcript with exon 2 spliced out
was detected. When capped RNAs were co-injected, the shorter tran-
script without exon 2 was observed and it is possible that this results
in a dominant negative protein. Our results from 4-IPP treatment
showed that blocking mif-function at the protein level had similar
effects on inner ear development, further strengthening the idea
that mif is a signiﬁcant player in inner ear organogenesis.Consistent with our studies of MIF function in SAG development in
both mouse and chick (Bank et al., submitted), the results of these
studies showed that themif pathway also plays crucial roles in zebra-
ﬁsh inner ear development. Our results also agreed with those of Ito
et al. (2008) in that, although mif MO treatment did not completely
abolish zebraﬁsh axis formation as was found in Xenopus (Suzuki
et al., 2004), the nervous system has been severely compromised,
including the brain, the eye, and the ear.
We have shown that mif, mif-like, iclp1, and iclp2 genes are
expressed in the ear, in addition to the brain and the eye, and the
timing of their expression coincides with critical stages in inner ear
development. The mif morphants had smaller brains, and increased
cell death in both the brain (as also observed by Ito et al., 2008) and
in the ear as shown in this report. However, the gross morphology
of the morphant ears was not affected, and early ear markers were
present in the same patterns as in normal control embryos, suggesting
that although the mif pathway has a role in early neurogenesis, it does
not affect the early gross morphogenesis of the inner ear. Instead, it
has a recurrent role at later stages including speciﬁcation, differentia-
tion, and maturation of individual inner ear cell types.
The increased cell death seen in mif morphants is consistent with
the role of mammalian MIF in preventing apoptosis in cells of the
immune system (Nishio et al., 2002). In the mammalian system, MIF
is thought to block apoptosis by inhibiting p53 activity (Mitchell et al.,
2002). Our results showed that a high concentration of p53 MO can
rescue the cell death caused by mif MOs, indicating an involvement of
Fig. 9. Development of lateral line (LL) in iclp morphants. (A–C) 4-Di-2-ASP staining of 72-hpf control (A), iclp morphant (B), and iclp morphant with capped RNAs (C).
(D–F) Phalloidin staining of posterior LL neuromast at 5 dpf in control (D), iclp MOs-injected (E), and iclp MOs plus RNA-injected (F) larvae. Scale bar: 100 μm for (A–C),
5 μm for (D–E). (G, H) Comparison of numbers of neuromast stained with 4-Di-2-ASP in control larvae and iclp morphants. Wt (n=10), MO (n=15).
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which mif inhibits cell death in the zebraﬁsh ear awaits further
investigation.
In addition to increased cell death, mif morphants had deformed
SCC, reduced HC/stereocilia, and much smaller SAGs. Iclp morphants
had fewer HC stained with phalloidin, as did the mif morphants, but
their semicircular canals and SAGs were not signiﬁcantly impacted.
It is possible that there is one or more receptor other than the
mammalian CD74 orthologs for mif in the zebraﬁsh, and that the
functions are split among the receptors. As mentioned earlier, CD44
is found to be expressed on pillar cells in the inner ear in the Tunnel
of Corti (Hertzano et al., 2010).
It is possible that there are additional MIF receptors in addition to
CD74, in the inner ear. Mif acts as a ligand of CXC chemokine receptors
to stimulate immune cells (Bernhagen et al., 2007), including Cxcr2
and Cxcr4. However no expression of cxcr2 in the developing inner
ear has yet been reported and we found none.
Cxcr4 is widely expressed in the vertebrate CNS (McGrath et al.,
1999; Tissir et al., 2004; Tiveron and Cremer, 2008; Zou et al.,
1998). Two zebraﬁsh cxcr4 orthologs have been found. In addition
to early expression of cxcr4 genes in lateral mesoderm and posterior
midbrain, interneurons and endoderm, sensory neurons,motorneurons
and cerebellum as well as the eye (Chong et al., 2001), cxcr4b is
expressed in the leading cells of the migrating LL primordia (Dambly-
Chaudière et al., 2007; Valentin et al., 2007). It is required for the
migration of the posterior LL primordia (Dambly-Chaudière et al.,
2007; Valentin et al., 2007). The expression of cxcr4 in the developing
zebraﬁsh ear has not been studied in detail, but preliminary ISH results
indicated that there is expression of cxcr4b in the region of the ear
(Dambly-Chaudière et al., 2007). However inner ear or later LL system
expression remains to be investigated. It will be intriguing to examine
the roles of both cxcr2 and cxcr4 in lateral line development, and to
determine whether they function as mif receptors in this tissue.
Since ODF is composed of numerous bioactive factors, most of
which are cytokines and many of which play neurotrophic roles in
other parts of the nervous system (Bianchi et al., 2005), we need to
investigate them sequentially to understand the interaction(s)
between/among them. It is likely that there is crosstalk amongmembers
of different cytokine subfamilies and the receptors that signal to
promote SAG neurite outgrowth. Dissecting the ODF cytokine-based“network” will help us understand the mechanism of how cytokines
function in inner ear development and, potentially, in SAG regeneration,
since the mature form of the SAG in mammals, the spiral ganglion
retains receptors for MIF (Bank et al., submitted).
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